Back to Search

Phase III Randomized, Open-Label, Multicenter Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide in Patients With Follicular Lymphoma After at Least One Line of Systemic Therapy

  • Protocol Number: 202106003
  • Principal Investigator: Bartlett, Nancy
  • Cancer Types: Lymphoma

For more information on this trial, contact us here:


Brief Summary

Protocol Interventions